Academic Journal

Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study.

التفاصيل البيبلوغرافية
العنوان: Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study.
المؤلفون: Montomoli, Marco, Roca, Lourdes, Rivera, Mariana, Fernandez-Prado, Raul, Redondo, Beatriz, Camacho, Rosa, Moyano, Cayetana, Pampa, Saul, Gonzalez, Angela, Casas, Juan, Kislikova, Maria, Sanchez Horrillo, Ana, Cabrera Cárdena, Alicia, Quiroga, Borja, Rabasco, Cristina, Piqueras, Sara, Suso, Andrea, Reque, Javier, Villa, Juan, Ojeda, Raquel
المصدر: Healthcare (2227-9032); Dec2022, Vol. 10 Issue 12, p2566, 10p
مصطلحات موضوعية: HEMORRHAGE risk factors, CHRONIC kidney failure complications, EMBOLISM risk factors, RESEARCH, GLOMERULAR filtration rate, PATIENT aftercare, ISCHEMIA, SCIENTIFIC observation, ANTICOAGULANTS, ATRIAL fibrillation, RETROSPECTIVE studies, CLINICS, RISK assessment, DESCRIPTIVE statistics, BENZOPYRANS, DEATH, LONGITUDINAL method, DISEASE risk factors
مستخلص: Atrial fibrillation (AF) is the most common arrhythmia in patients with chronic kidney disease (CKD), and its presence is associated with a higher risk of stroke and mortality. Material and Methods: The FAERC study performed a retrospective multicentre analysis of historical cohorts in which data were collected from arrhythmia diagnosis onwards. Results: We analysed a Spanish cohort of 4749 patients with CKD (mean eGFR 33.9 mL/min) followed up in the nephrology clinic, observing a 12.2% prevalence of non-valvular AF. In total, 98.6% of these patients were receiving anticoagulant treatment, mainly with coumarins (79.7%). Using direct-acting oral anticoagulants (DOACs) was associated with fewer cerebrovascular events than using acenocoumarol, but in contrast with other studies, we could not corroborate the association of risk of bleeding, coronary events, or death with a type of anticoagulant prescribed. Conclusions: Atrial fibrillation is highly prevalent in renal patients. Direct-acting anticoagulants seem to be associated with fewer ischemic-embolic complications, with no differences in bleeding, coronary events, or mortality rates. [ABSTRACT FROM AUTHOR]
Copyright of Healthcare (2227-9032) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:22279032
DOI:10.3390/healthcare10122566